| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.LUNGCAN.2009.05.007 |
| P698 | PubMed publication ID | 19556022 |
| P50 | author | Andrea Riccardo Filippi | Q38323465 |
| Umberto Ricardi | Q38323481 | ||
| Pierfrancesco Franco | Q38323495 | ||
| Riccardo Ragona | Q47503194 | ||
| P2093 | author name string | Giorgio Vittorio Scagliotti | |
| Cristina Mantovani | |||
| Alessia Guarneri | |||
| Francesca Romana Giglioli | |||
| Patrizia Ciammella | |||
| Piero Borasio | |||
| P433 | issue | 1 | |
| P921 | main subject | lung cancer | Q47912 |
| P304 | page(s) | 72-77 | |
| P577 | publication date | 2009-06-24 | |
| P1433 | published in | Lung Cancer | Q641464 |
| P1476 | title | Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial | |
| P478 | volume | 68 |
| Q28079625 | A critical review of recent developments in radiotherapy for non-small cell lung cancer |
| Q36119520 | A review of update clinical results of carbon ion radiotherapy |
| Q38790915 | A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer |
| Q57498590 | Accelerated Hypofractionated Radiotherapy Versus Stereotactic Body Radiotherapy for the Treatment of Stage I Nonsmall Cell Lung Cancer-A Single Institution Experience With Long-Term Follow-Up |
| Q41318171 | An Integrated Nanotechnology-Enabled Transbronchial Image-Guided Intervention Strategy for Peripheral Lung Cancer |
| Q30585045 | Analysis of first recurrence and survival in patients with stage I non-small cell lung cancer treated with surgical resection or stereotactic radiation therapy |
| Q26823670 | Are three doses of stereotactic ablative radiotherapy (SABR) more effective than 30 doses of conventional radiotherapy? |
| Q36599965 | Carbon ion radiotherapy for oligo-recurrence in the lung |
| Q64266974 | Changes in quality of life after surgery or radiotherapy in early-stage lung cancer |
| Q35150641 | Clinical analysis of stereotactic body radiation therapy using extracranial gamma knife for patients with mainly bulky inoperable early stage non-small cell lung carcinoma |
| Q47103518 | Clinical outcomes following image-guided stereotactic body radiation for pulmonary oligometastases |
| Q49356303 | Clinical outcomes following image-guided stereotactic body radiation for pulmonary oligometastases |
| Q37060393 | Clinical outcomes of video-assisted thoracic surgery and stereotactic body radiation therapy for early-stage non-small cell lung cancer: A meta-analysis |
| Q40835700 | Comparison of Clinical Outcomes of VATS and SBRT in the Treatment of NSCLC |
| Q47446694 | Comparison of Single- and Three-fraction Schedules of Stereotactic Body Radiation Therapy for Peripheral Early-stage Non-Small-cell Lung Cancer. |
| Q36382039 | Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating meta-analysis |
| Q38914996 | Comparison of the Effectiveness of Radiofrequency Ablation With Stereotactic Body Radiation Therapy in Inoperable Stage I Non-Small Cell Lung Cancer: A Systemic Review and Pooled Analysis. |
| Q35990998 | Computed tomographic features predictive of local recurrence in patients with early stage lung cancer treated with stereotactic body radiation therapy |
| Q41920328 | Computed tomography fluoroscopy-guided percutaneous (125)I seed implantation for safe, effective and real-time monitoring radiotherapy of inoperable stage T1-3N0M0 non-small-cell lung cancer |
| Q37468265 | Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer |
| Q36661346 | Differences in the dose-volume metrics with heterogeneity correction status and its influence on local control in stereotactic body radiation therapy for lung cancer |
| Q42321832 | Dosimetric evaluation of the impacts of different heterogeneity correction algorithms on target doses in stereotactic body radiation therapy for lung tumors |
| Q41909998 | Efficient approach for determining four-dimensional computed tomography-based internal target volume in stereotactic radiotherapy of lung cancer |
| Q37645201 | Emerging treatment options in the management of non-small cell lung cancer. |
| Q50667985 | Evaluation of interfractional variation of the centroid position and volume of internal target volume during stereotactic body radiotherapy of lung cancer using cone-beam computed tomography. |
| Q38276603 | Evolution of hypofractionated accelerated radiotherapy for prostate cancer - the sunnybrook experience |
| Q57058757 | Final report of survival and late toxicities in the Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702) |
| Q91868558 | Impact of Tumor Size on Local Control and Pneumonitis After Stereotactic Body Radiation Therapy for Lung Tumors |
| Q26863239 | Innovative technologies in thoracic radiation therapy for lung cancer |
| Q38233871 | Is stereotactic ablative radiotherapy an alternative to surgery in operable stage I non-small cell lung cancer? |
| Q26864983 | Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with stage I non-small-cell lung cancer? |
| Q38705115 | Limitations of PET/CT in the Detection of Occult N1 Metastasis in Clinical Stage I(T1-2aN0) Non-Small Cell Lung Cancer for Staging Prior to Stereotactic Body Radiotherapy |
| Q47149089 | Low and medium doses of hypofractionated stereotactic radiotherapy could be suboptimal for early-stage lung cancer |
| Q37175657 | Lung stereotactic ablative radiotherapy (SABR): dosimetric considerations for chest wall toxicity |
| Q84632256 | Lung-cancer related chest events detected by periodical follow-up CT after stereotactic body radiotherapy for stage I primary lung cancer: retrospective analysis of incidence of lung-cancer related chest events and outcomes of salvage treatment |
| Q36235727 | LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective |
| Q37659318 | Marginal prescription equivalent to the isocenter prescription in lung stereotactic body radiotherapy: preliminary study for Japan Clinical Oncology Group trial (JCOG1408) |
| Q37044288 | Microsimulation model predicts survival benefit of radiofrequency ablation and stereotactic body radiotherapy versus radiotherapy for treating inoperable stage I non-small cell lung cancer |
| Q36736164 | Minibeam therapy with protons and light ions: physical feasibility and potential to reduce radiation side effects and to facilitate hypofractionation |
| Q35687174 | Minimal Inter-Fractional Fiducial Migration during Image-Guided Lung Stereotactic Body Radiotherapy Using SuperLock Nitinol Coil Fiducial Markers |
| Q40656245 | Multicenter prospective study of sublobar resection for c-stage I non-small cell lung cancer patients unable to undergo lobectomy (KLSG-0801): complete republication |
| Q64962639 | Novel approach for predicting occult lymph node metastasis in peripheral clinical stage I lung adenocarcinoma. |
| Q49749018 | Optimizing the prescription isodose level in stereotactic volumetric-modulated arc radiotherapy of lung lesions as a potential for dose de-escalation |
| Q33826696 | Outcomes after stereotactic body radiotherapy for lung tumors, with emphasis on comparison of primary lung cancer and metastatic lung tumors |
| Q64277127 | Phase II study of compensator-based non-coplanar intensity-modulated radiotherapy for Stage I non-small-cell lung cancer |
| Q56528378 | Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie? |
| Q89996520 | Prognostic impact of solid tumor component diameter in early-stage non-small cell lung carcinoma treated with intensity-modulated fractionated radiotherapy: a retrospective analysis impact of solid tumor component diameter in NSCLC treated with IMRT |
| Q38256158 | Radiation pneumonitis after stereotactic radiation therapy for lung cancer |
| Q37007890 | Radiation therapy for early stage lung cancer |
| Q33787072 | Radiofrequency ablation for early-stage nonsmall cell lung cancer |
| Q35200592 | SBRT in operable early stage lung cancer patients. |
| Q42384628 | SBRT versus lobectomy in stage I NSCLC: knowns, unknowns and its interpretation |
| Q38161371 | Scalpel or SABR for Treatment of Early-Stage Lung Cancer: Clinical Considerations for the Multidisciplinary Team |
| Q89005809 | Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC) |
| Q60912983 | Stereotactic body radiation therapy for non-small cell lung cancer: A review |
| Q36555959 | Stereotactic body radiation therapy for the treatment of early-stage minimally invasive adenocarcinoma or adenocarcnioma in situ (formerly bronchioloalveolar carcinoma): a patterns of failure analysis. |
| Q38560967 | Stereotactic body radiotherapy (SBRT) for the treatment of inoperable stage I non-small cell lung cancer patients |
| Q50851277 | Stereotactic body radiotherapy for cardiac and paracardiac metastases: University of Florence experience. |
| Q53054421 | Stereotactic body radiotherapy for centrally located stage I NSCLC: a multicenter analysis. |
| Q42033188 | Stereotactic body radiotherapy for small lung tumors in the University of Tokyo Hospital |
| Q38175120 | Stereotactic body radiotherapy: a critical review for nonradiation oncologists |
| Q28076058 | Stereotactic body radiotherapy: current strategies and future development |
| Q35824255 | Stereotactic radiotherapy for early stage non-small cell lung cancer |
| Q26748296 | Surgery versus stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer: less is not more |
| Q48369218 | Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review. |
| Q36642258 | The use of isodose levels to interpret radiation induced lung injury: a quantitative analysis of computed tomography changes |
| Q58584561 | Treatment-Related Adverse Effects in Lung Cancer Patients after Stereotactic Ablative Radiation Therapy |
| Q39015830 | Tumor control probability modeling for stereotactic body radiation therapy of early-stage lung cancer using multiple bio-physical models. |
| Q40342856 | What is the current status of Stereotactic body radiotherapy for stage I non-small cell lung cancer? |
| Q38172228 | What would be the most appropriate α/β ratio in the setting of stereotactic body radiation therapy for early stage non-small cell lung cancer |
| Q92467682 | Which patients benefit most from stereotactic body radiotherapy or surgery in medically operable non-small cell lung cancer? An in-depth look at patient characteristics on both sides of the debate |
| Q55441727 | [Radiation pneumonitis after stereotactic body radiation therapy for early stage non-small cell lung cancer]. |
| Q53288899 | [Stereotactic body radiaton therapy for 15 patients with small lung neoplasms]. |
Search more.